Breast Cancer Blood Test Panel
The Breast Cancer Blood Test Panel helps screen for and monitor invasive breast cancer.
CPT Code(s):
See Individual Tests
Methodology:
See individual tests.
Preparation:
No fasting is required. Patients should stop biotin consumption at least 72 hours prior to the collection.
Test Results:
1-2 days. May take longer based on weather, holiday, or lab delays.
Walk-In Lab is prohibited from selling LabCorp tests to residents in the following states:NY, NJ, RI, MA, MD
CPT Code(s):
See Individual Tests
Methodology:
See individual tests.
Preparation:
No fasting is required. Patients should stop biotin consumption at least 72 hours prior to the collection.
Test Results:
1-2 days. May take longer based on weather, holiday, or lab delays.
Walk-In Lab is prohibited from selling Quest tests to residents in the following states:AZ, NY, NJ, RI
What is the purpose of this test?
Order this Breast Cancer Blood Test Panel, which assists in detecting and monitoring invasive breast cancer. Breast cancer is a type of cancer that begins in breast tissue and occurs when cells grow out of control, forming a tumor. It can be "in situ" or "invasive" if it spreads outside the breast. Breast cancer is the second most common cancer in women in the United States and can also affect men.
The primary function of this panel is to screen for early signs of the disease, enabling timely medical intervention and improving the chances of successful treatment. Additionally, it provides continuous monitoring of the patient's condition, allowing for prompt action if any changes or developments occur. Overall, this panel represents a significant improvement in the fight against breast cancer and offers hope to those affected by this devastating illness.
What tests are included in this panel?
The Breast Cancer Blood Test Panel includes the following:
- Cancer Antigen (CA) 27.29 - CA 27.29 is a crucial protein that serves as a tumor marker to evaluate an individual's progression of metastatic breast cancer.
- Cancer Antigen (CA) 15-3 - CA 15-3 is a tumor marker produced by specific cancer cells, like breast cancer, and released into the bloodstream. It can provide important information about the presence and progression of breast cancer.
- Carcinoembryonic Antigen (CEA) - CEA is a protein linked to some cancers, including breast cancer. CEA testing is not for cancer diagnosis but can help predict cancer progression, treatment effectiveness, and cancer recurrence.
Who may be at risk for developing breast cancer?
Several factors can increase a person's risk of developing breast cancer. It is essential to be aware of these risk factors so that preventative measures can be taken. These factors include:
- Advancing in age
- If someone has a history of breast cancer or benign (noncancerous) breast disease.
- Family history of breast cancer, including having BRCA1 and BRCA2 gene mutations
- Dense breast tissue
- A reproductive history that results in increased exposure to the estrogen hormone, including
- Starting menstruation at an early age
- Giving birth at an older age or never having given birth
- Experiencing menopause at a later age
- Taking hormone therapy for symptoms of menopause
- Radiation therapy to the breast or chest
- Obesity
- Drinking alcohol
When should I order a Breast Cancer Blood Test Panel?
Individuals may order this panel if they have experienced symptoms related to breast cancer. Common signs and symptoms of breast cancer include:
- A new lump or thickening in your breast or under your arm.
- An alteration in the size or shape of your breast.
- A dimple or puckering in the skin of the breast, similar in appearance to the skin of an orange.
- The nipple is inverted and pointing inward towards the breast.
- Nipple discharge that is not breast milk, especially if it is sudden, bloody, or only from one breast.
- Scaly, red, or swollen skin around your nipple or breast area
- Experiencing pain in any part of the breast.
